Definitive Contract W911NF16C0055
Award Date 3/21/16
Potential Completion Date 12/20/16
Potential Value $548K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $5,162,303.00 Firm Fixed Price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Hvivo Services LIMITED, a foreign-owned for-profit organization, for research and development in accordance with the statement of work entitled "First Influenza Recognition and Elucidation". The contract was awarded on September 8, 2017, with a completion date of July 26, 2019, and does not have a set-aside designation. The place of performance is Great...
- Evidation Health, Inc., a for-profit digital health analytics company, was awarded a $749,000.00 firm fixed price contract by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop a novel respiratory virus detection and forecasting model. This contract is related to the Pandemic and All Hazard Preparedness Act and was awarded under a Broad Agency Announcement seeking innovations in health security solutions. The contract has...
- <p>This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Janus-I Science Inc., a self-certified small disadvantaged business, for the "PROMETHEUS PROGRAM - PREDICTING INFLUENZA CONTAGIOUSNESS PRIOR TO SYMPTOM DISPLAY" with a ceiling value of $4,893,764.00. The contract has an ultimate completion date of November 15, 2020 and was awarded on September 6, 2017. There was no set-aside used for this contract.</p>
- This is a $3,007,557.97 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of new platform technologies for viral and therapeutic evolution assays under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a firm fixed price pricing type and a period of performance through November 2022. Autonomous Therapeutics has also...
- The Office of the Assistant Secretary for Preparedness and Response awarded a $61.98 million definitive cost-plus-fixed-fee contract to The Charles Stark Draper Laboratory, Inc. on September 29, 2023, for the development of a medical countermeasure evaluation platform. The platform will integrate vascular-immune and small intestine-immune organ-on-chip models with molecular assays, omics-based technologies, and advanced analytical methods for biomarker discovery. Work will be performed in...
- This is a federal contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Charles River Analytics, Inc., a small business based in Cambridge, Massachusetts. The contract, with a potential value of $26,909,114.00, is for the development and delivery of a health and injury prediction and prevention mobile application using complex reasoning and analytical techniques. The contract does not have a set-aside designation. Charles River Analytics is the prime contractor, and two...
- <p>This is a firm fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA), a defense agency, to Neumitra, Inc., a for-profit organization. The contract award, with a ceiling value of $140,967.88, was made on June 10, 2016, and has an ultimate completion date of July 9, 2016. The contract does not have a set-aside designation. The contract is for work to be performed in Boston, MA.</p>
- This is a $13,166,673.00 cost-plus-fixed-fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to A2 Labs, LLC, doing business as Kryptowire, LLC, a cybersecurity research and development firm. The contract is for the "SENSING HEALTH INNOVATIVELY USING NOVEL EMPIRICISM (SHINE)" program and has a completion date of February 22, 2023. The contract does not have a set-aside designation. Kryptowire, a small business entity, has established itself as a trusted...
- This contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business, for the development of a host-response prognostic tool called HOSTDXTM-COVID SEVERITY. The $453,851.00 contract is for research, development, and testing services related to diagnostic solutions for COVID-19 and other viral pandemics. Inflammatix has received over $29 million in federal contracts and grants from the Department of Health and Human Services to...
- This federal contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Stottler Henke Associates, Inc. (SHAi), a small business technology company, for a Small Business Innovation Research (SBIR) Phase II research effort. The contract, valued at $1,499,933.00, is focused on "Identifying Meaningful Indicators of Collective Allostatic Load from Low-Cost, Wearable Sensors." As a small business set-aside, this award allows SHAi to continue its research and...